We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Handheld Pen Enables Real-Time Tissue Identification during Surgery

By LabMedica International staff writers
Posted on 30 Aug 2023
Print article
Image: The MasSpec Pen being used to probe tissue during surgery (Photo courtesy of Baylor College of Medicine)
Image: The MasSpec Pen being used to probe tissue during surgery (Photo courtesy of Baylor College of Medicine)

Thyroid and parathyroid gland surgeries pose significant challenges, even for experienced surgeons. These relatively small neck structures share characteristics like color and texture, complicating visual differentiation. For instance, during thyroid removal procedures, accidental parathyroid removal occurs in about 25% of cases. Similarly, unsuccessful parathyroid removals often result from the inability to locate and resect diseased parathyroid tissue, as thyroid nodules and lymph nodes can be mistaken for parathyroid tissue. There is a critical need for innovative methods to preserve healthy tissue and ensure precise resection.

In a new project, surgeons at Baylor College of Medicine (Houston, TX, USA) extensively tested the MasSpec Pen during thyroid and parathyroid surgeries. In the operating room, the MasSpec Pen helps surgeons identify tissues for resection before actually performing the procedure, ensuring accurate tissue removal without unnecessary damage. Integrating seamlessly into the surgical workflow, the pen can be sterilized like other instruments and simply connected to the mass spectrometer. Its intuitive use holds immense potential for saving time during surgery. The pen primarily detects small molecules like metabolites (cell metabolism byproducts) and lipids created by cells. Each tissue has a unique metabolite and lipid pattern. While many molecules are similar across tissues, their concentrations vary based on tissue type, enabling surgeons to differentiate tissues. The process is simple: the surgeon places the pen gently on the tissue, which deposits a droplet of room-temperature sterile water, extracting small molecules. The droplet is then directed to a real-time mass spectrometer that reveals the tissue's molecular composition, indicating its type. Importantly, this procedure does not harm the analyzed tissues.

In order to assess the precision of this novel technology, the scientists conducted a comparison between the tissue identification outcomes produced by the MasSpec Pen and the well-established method of tissue identification—pathology analysis. Pathologists are experts who specialize in microscopically discerning tissue samples. The MasSpec Pen exhibited exceptional accuracy in distinguishing thyroid, parathyroid, and lymph node tissues during surgeries, achieving accuracy rates exceeding 90%. Results from the MasSpec Pen analysis were available in around 20 seconds, whereas processing samples for pathology analysis (referred to as frozen section) during surgery can extend to an hour, thus saving both procedure time and cost. Typically, prolonged surgeries heighten the risk of complications. The use of the MasSpec Pen offers the benefit of real-time tissue identification during surgical procedures, enhancing patient care.

“The MasSpec Pen could be applied to surgeries of other organs, such as lungs or pancreas,” said co-corresponding author Dr. James Suliburk, associate professor of surgery and member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. “We think this can really revolutionize how we do surgery.”

Related Links:
Baylor College of Medicine

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.